Read + Share
Amedeo Smart
Independent Medical Education
Mooradian MJ, Cleary JM, Giobbie-Hurder A, Darville LNF, et al. Dose-escalation trial of combination dabrafenib, trametinib, and AT13387 in patients with BRAF-mutant solid tumors. Cancer 2023;129:1904-1918.PMID: 37042037
Email
LinkedIn
Facebook
Twitter
Privacy Policy